"Urologists today are armed with 2 guideline-supported modalities to reduce the burden of unnecessary biopsies while maintaining timely detection of clinically significant cancers," write the authors.
Ian M. McElree, MD
Advertisement
McElree is a urology resident at Vanderbilt University Medical Center in Nashville, Tennessee.
Articles by Ian M. McElree, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Clinical Application of MMAI Score in Patients with Prostate Cancer
2
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
3
Setting the Stage: ADT in Intermediate-Risk Prostate Cancer
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5